Cervical Lesion
Cervical Lesion - most related articles:
-
IUDs may lower cervical cancer risk - 5.4
-
Gardasil vaccine to prevent cervical cancer in India - 5.3
-
Regular pap tests boost chances of cure from cervical cancer - 5.3
-
Early cervical cancer screening may harm women - 5.2
-
Cervical cancer screening to 50000 women in India - 5.1
-
HPV DNA testing for all women aged 29 years and above - 4.9
-
Persistent HPV infection raises cervical cancer risk - 4.8
-
TV ad to educate women about cervical cancer and HPV test - 4.6
-
HPV vaccine Cervarix in UK's immunisation programme - 4.5
-
Cervical cancer screening should be less frequent - 4.3
Cervical Lesion articles
Gardasil efficacious against HPV 16 infectionIn a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.
Gardasil HPV vaccine prevented genital lesions in menGARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.
Gardasil vaccine to prevent cervical cancer in IndiaMSD Pharmaceuticals India announced the launch of GARDASIL Vaccine, India's first vaccine to help prevent Cervical Cancer caused by the HPV.
3 Cervical Lesion articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.